Enhabit Inc

Enhabit, Inc. functions as an investment holding company. It provides home health and hospice services. Its Home Health services give patients access to the care they deserve in the comfort of their own homes. From disease and injury management to recovery from surgery, clinicians help patients confidently achieve their healthcare goals. The firm's Hospice services place importance on the comfort of every patient living with a terminal illness. The company was founded in 2014 and is headquartered in Dallas, TX.

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Enhabit Inc reports solid Q4 performance amidst strategic changes

Enhabit Inc showcased solid financial performance in Q4 2022, with notable strengths in strategic changes and operational effectiveness.
Challenges include revenue impact from payer shifts and cost pressures, while opportunities lie in revenue growth and optimizing operational efficiency.
The company's focus on acquisitions, patient care optimization, and disciplined growth strategies will be key for future success.
Enhabit's performance, strengths, challenges, and opportunities position it for continued growth and operational excellence in the Home Health and Hospice sectors.

Enhabit Inc reports mixed Q1 results, focuses on growth opportunities

Enhabit Inc saw mixed performance with revenue decline but strong EBITDA guidance.
Challenges include lower patient days in hospice and rising G&A costs.
Opportunities lie in expanding patient accessibility and driving incremental volume.
Overall, Enhabit is focused on independent operation amidst industry consolidation.

Enhabit Inc reports strong growth amidst Medicare Advantage challenges

Enhabit Inc showcased strong performance in non-episodic admissions and cash flow generation, while facing challenges from Medicare Advantage shifts.
The company's strengths lie in recruitment efforts, successful negotiations, and strategic focus on hospice management.
Challenges include maintaining relationships amidst market shifts and diversifying patient mix in hospice.
Opportunities exist in addressing challenges through recruitment strategies, strategic alternatives, and adapting to market changes.

Enhabit reports Q3 revenue decline but secures covenant relief

Enhabit Inc's Q3 2023 performance reflected revenue and EBITDA declines, but strategic initiatives and financial management strength support future growth prospects.
The company's recognition for workplace culture and operational focus are key strengths, while challenges in admissions and financial metrics require targeted solutions.
Opportunities in Medicare pricing, volume growth, and hospice segment trends offer avenues for Enhabit to drive revenue and operational improvements in the coming quarters.

Enhabit Inc reports Q4 results, eyes growth through strategic initiatives

Enhabit Inc's Q4 2023 performance showed mixed results with revenue decline but growth in key segments, setting the stage for strategic initiatives in 2024.
The company's focus on payer innovation contracts, Medicare Advantage transitions, and hospice case management highlights a path for future growth and operational excellence.
While facing challenges in contract predictability and regulatory uncertainties, Enhabit's strengths in contract quality and operational performance present opportunities for sustained success.
Enhabit's financial outlook for 2024 includes a focus on revenue growth, cost management, and strategic expansion, positioning the company for continued progress and profitability.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Enhabit, Inc. functions as an investment holding company. It operates under the Home Health and Hospice segments. The Home Health segment provides home health services via home nursing services to adult patients in need of care. The Hospice segment offers hospice agencies. The company was founded in 2014 and is headquartered in Dallas, TX.

NEW YORK--(BUSINESS WIRE)--AREX Capital Management, LP (together with its affiliates, “AREX”), the beneficial owner of approximately 4.9% of the outstanding common shares of Enhabit, Inc. (NYSE: EHAB) (“Enhabit” or the “Company”), today announced that Institutional Shareholder Services Inc. (“ISS”), a leading independent proxy advisory firm, has recommended that Enhabit's stockholders support meaningful boardroom change by voting for three of its director candidates at the Company's 2024 Annual.

ISS Recommends Stockholders Support Meaningful Change at Enhabit by Voting the WHITE Proxy Card “FOR” Three of AREX Capital's Nominees

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB) (“Enhabit” or the “Company”), a leading home health and hospice provider, today announced that Institutional Shareholder Services (ISS) has recommended stockholders vote “FOR” a majority of Enhabit's director nominees in connection with the Company's Annual Meeting of Stockholders scheduled for July 25, 2024. Enhabit's definitive proxy materials and other materials regarding the Board of Directors' recommendations for the 2024 Annual Meeting c.

ISS Recommends Stockholders Vote “FOR” a Majority of Enhabit Home Health & Hospice Director Nominees

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its results for the second quarter ended June 30, 2024, on Aug. 6, 2024, and host a webcast and conference call on Aug. 7, 2024. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. Aug. 7, 2024 10 a.m. EDT Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 Inte.

Enhabit Home Health & Hospice Announces Date of 2024 Second Quarter Earnings Call

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB) (“Enhabit” or the “Company”), a leading home health and hospice provider, today sent a letter to stockholders in connection with its upcoming 2024 Annual Meeting of Stockholders scheduled for July 25, 2024. Stockholders of record, as of the close of business on June 5, 2024, are entitled to vote at the 2024 Annual Meeting. The full text of the letter follows and can be found at investors.ehab.com/2024-annual-meeting/, along with Enhabit's defi.

Enhabit Reiterates That its Current Board is Best Positioned to Deliver Enhanced Value in Letter to Stockholders

NEW YORK--(BUSINESS WIRE)--AREX Capital Management, LP (together with its affiliates, “AREX”), the beneficial owner of approximately 4.9% of the outstanding common shares of Enhabit, Inc. (NYSE: EHAB) (“Enhabit” or the “Company”), today issued an open letter to its fellow stockholders expressing its disappointment in the Company's recent investor presentation, which it believes recycles the same excuses and makes the same empty promises on which the Company has repeatedly failed to deliver. The.

AREX Capital Expresses Disappointment in Enhabit's Continued Excuses and Empty Promises

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced that it has posted an investor presentation today in connection with its Annual Meeting of Stockholders (the “2024 Annual Meeting”) scheduled for July 25, 2024. Stockholders of record as of the close of business on June 5, 2024, are entitled to vote at the 2024 Annual Meeting. The presentation can be found at investors.ehab.com/2024-annual-meeting/. The Enhabit Board of Directors iss.

Enhabit Releases Investor Presentation Demonstrating Execution of Clear Growth Strategy and Path to Unlock Shareholder Value

NEW YORK--(BUSINESS WIRE)--AREX Capital Management, LP (together with its affiliates, “AREX”), the beneficial owner of approximately 4.9% of the outstanding common shares of Enhabit, Inc. (NYSE: EHAB) (“Enhabit” or the “Company”), today issued a presentation detailing the AREX Slate's comprehensive plan to turn around Enhabit's operational performance and reduce costs, which AREX believes could increase EBITDA by 50%. The presentation can be accessed here: Rehabilitate Enhabit. As a reminder, A.

AREX Capital Releases Presentation Detailing Its Nominees' Comprehensive Plan to Deliver Enduring Value for Enhabit Stockholders

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), (“Enhabit” or the “Company”), a leading home health and hospice provider, today sent a letter to stockholders in connection with its upcoming 2024 Annual Meeting of Stockholders (the “2024 Annual Meeting”) scheduled for July 25, 2024. Stockholders of record as of the close of business on June 5, 2024 are entitled to vote at the 2024 Annual Meeting. The Company issued the following letter to Enhabit Stockholders to address misstatements made b.

Enhabit Demonstrates Progress to Stabilize Business and Position Company for Profitable Growth

NEW YORK--(BUSINESS WIRE)--AREX Capital Management, LP (together with its affiliates, “AREX” or “we”), the beneficial owner of approximately 4.9% of the outstanding common shares of Enhabit, Inc. (NYSE: EHAB) (“Enhabit”), today issued an open letter to its fellow stockholders regarding the misleading statements in Enhabit's recent communications. The full text of the letter can be found here: AREX Sets the Record Straight. We believe voting for all seven of AREX's nominees on the WHITE proxy ca.

AREX Capital Sets the Record Straight Regarding Enhabit's Misleading Assertions

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB) (“Enhabit” or the “Company”), a leading home health and hospice provider, today announced that it has filed definitive proxy materials with the Securities and Exchange Commission in connection with its upcoming 2024 annual meeting of stockholders (the “2024 Annual Meeting”) scheduled for July 25, 2024. Stockholders of record as of the close of business on June 5, 2024, are entitled to vote at the 2024 Annual Meeting. In connection with the fil.

Enhabit Details Decisive Actions to Successfully Stabilize Business and Position Company for Value Creation

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB) (“Enhabit” or the “Company”) today announced that it has filed its preliminary proxy materials with the Securities and Exchange Commission (the “SEC”) in connection with its upcoming 2024 annual meeting of stockholders (the “2024 Annual Meeting”). The preliminary proxy statement is available on the Investor Relations section of the Enhabit website at investors.ehab.com. The Company is filing a preliminary proxy statement because AREX Capital M.

Enhabit Provides Additional Details on Robust Strategic Review Process

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced its participation in the Goldman Sachs 45th Annual Global Healthcare Conference. Enhabit's President and Chief Executive Officer Barbara Jacobsmeyer and Chief Financial Officer Crissy Carlisle will participate in a fireside chat on Tuesday, June 11, at 10 a.m. EDT. The fireside chat will be webcast live and available for replay at https://investors.ehab.com. About Enhabit Ho.

Enhabit Announces Participation in Upcoming Goldman Sachs 45th Annual Global Healthcare Conference

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced its participation in the Leerink Partners Healthcare Crossroads Conference 2024. Enhabit's President and Chief Executive Officer Barbara Jacobsmeyer and Chief Financial Officer Crissy Carlisle will participate in a fireside chat on Wednesday, May 29, at 10 a.m. CDT. The fireside chat will be webcast live and available for replay at https://investors.ehab.com. About Enhabit H.

Enhabit Announces Participation in Upcoming Leerink Partners Healthcare Crossroads Conference 2024

Enhabit, Inc. (NYSE:EHAB ) Q1 2024 Earnings Conference Call May 9, 2024 10:00 AM ET Company Participants Barb Jacobsmeyer - President, CEO Crissy Carlisle - CFO Conference Call Participants A.J. Rice - UBS Jason Cassorla - Citi Joanna Gajuk - Bank of America Ryan Langston - TD Cowen Operator Good morning, everyone, and welcome to Enhabit Home Health and Hospice's First Quarter 2024 Earnings Conference Call.

Enhabit, Inc. (EHAB) Q1 2023 Earnings Call Transcript

Enhabit (EHAB) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.09 per share a year ago.

Enhabit (EHAB) Beats Q1 Earnings Estimates

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice provider, today announced Enhabit's Board of Directors (the “Board”) has concluded the Company's strategic review process, announced in August 2023, which was overseen by the Board with assistance from its financial and legal advisors, Goldman Sachs and Sidley Austin, respectively. After evaluating a full range of strategic alternatives, including a potential sale, merger or other transaction, the Board unani.

Enhabit Concludes Review of Strategic Alternatives

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the first quarter ended March 31, 2024. “Our momentum exiting 2023 and through the first quarter of 2024 instills confidence and excitement in our strategy and team,” said Enhabit's President and Chief Executive Officer Barb Jacobsmeyer. “Our strong start to 2024 is a result of our team's continued focus on our operational strategies. Additional fron.

Enhabit Reports First Quarter 2024 Financial Results

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its results for the first quarter ended March 31, 2024, on May 8, 2024, and host a webcast and conference call on May 9, 2024. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. May 9, 2024 10 a.m. EDT Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 Interne.

Enhabit Home Health & Hospice Announces Date of 2024 First Quarter Earnings Call

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it has earned the 2024 Top Workplaces USA award issued by Energage. The Top Workplaces program has a 15-year history of surveying more than 20 million employees and recognizing top organizations across 60 markets. Winners of the Top Workplaces USA award are chosen based solely on employee feedback gathered through an employee engagement survey issued by Energage. Results are.

Enhabit Home Health & Hospice Named a Winner of the 2024 Top Workplaces USA Award

Enhabit, Inc. (NYSE:EHAB ) Q4 2023 Results Conference Call March 7, 2024 10:00 AM ET Company Participants Barb Jacobsmeyer - President, CEO Crissy Carlisle - CFO Conference Call Participants Brian Tanquilut - Jefferies Jason Cassorla - Citi Joanna Gajuk - Bank of America Enjia Cao - UBS Ryan Langston - TD Cowen Operator Good morning, everyone. Welcome to Enhabit Home Health and Hospice's Fourth Quarter 2023 Earnings Conference Call.

Enhabit, Inc. (EHAB) Q4 2023 Earnings Call Transcript

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended December 31, 2023. “Persistent focus on our Company's strategies drove our positive fourth quarter results,” said Enhabit's President and Chief Executive Officer Barb Jacobsmeyer. “Payor innovation success, including the finalization of another new national contract, continued success with our people strategy and strong perfo.

Enhabit Reports Fourth Quarter Results and Issues Full-Year 2024 Guidance

DALLAS--(BUSINESS WIRE)--Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its results for the fourth quarter ended Dec. 31, 2023, on March 6, 2024, and host a webcast and conference call on March 7, 2024. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. March 7, 2024 10:00 a.m. Eastern Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 52.

Enhabit Home Health & Hospice Announces Date of 2023 Fourth Quarter Earnings Call

Enhabit, Inc. (NYSE:EHAB ) Q3 2023 Results Conference Call November 8, 2023 10:00 AM ET Company Participants Jordan Loyd - Mergers & Acquisitions Director, Corporate Development Barb Jacobsmeyer - President and Chief Executive Officer Crissy Carlisle - Chief Financial Officer Conference Call Participants Brian Tanquilut - Jefferies Joanna Gajuk - Bank of America Whit Mayo - Leerink Partners Jamie Perse - Goldman Sachs Operator Good morning, everyone, and welcome to Enhabit Home Health & Hospice's Third Quarter 2023 Earnings Conference Call. At this time, I'd like to inform all participants that their lines will be in a listen-only mode.

Enhabit, Inc. (EHAB) Q3 2023 Earnings Call Transcript

LOS ANGELES, CA / ACCESSWIRE / November 9, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Enhabit, Inc. ("Enhabit" or "the Company") (NYSE:EHAB) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Enhabit, Inc. and Encourages Investors with Losses to Contact the Firm

Enhabit (EHAB) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.19 per share a year ago.

News for Enhabit Inc Stock (EHAB)